Article info

Download PDFPDF

NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors

Authors

  1. Correspondence to Dr Xiang-Yu Meng; mengxy_whu{at}163.com

Citation

Meng X
NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors

Publication history

  • Accepted May 17, 2023
  • First published June 5, 2023.
Online issue publication 
June 05, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.